Last $46.91 USD
Change Today +0.64 / 1.38%
Volume 239.5K
LCI On Other Exchanges
New York
As of 8:04 PM 07/11/14 All times are local (Market data is delayed by at least 15 minutes).

lannett co inc (LCI) Snapshot

Previous Close
Day High
Day Low
52 Week High
07/3/14 - $51.66
52 Week Low
08/9/13 - $11.75
Market Cap
Average Volume 10 Days
Shares Outstanding
Dividend Yield
Current Stock Chart for LANNETT CO INC (LCI)

Related News

No related news articles were found.

lannett co inc (LCI) Related Businessweek News

No Related Businessweek News Found

lannett co inc (LCI) Details

Lannett Company, Inc. develops, manufactures, packages, markets, and distributes generic versions of branded pharmaceutical products in the United States. It offers solid oral, extended release, topical, and oral solution finished dosage forms of drugs that address a range of therapeutic areas. The company provides its products for various medical indications comprising glaucoma, migraine, antibiotic, anesthetic, endometriosis, irritable bowel syndrome, obesity, congestive heart failure, antipsychotic, pain management, thyroid deficiency, dryness of the mouth, epilepsy, gout, bronchospasms, hypertension, and gallstone. Lannett Company, Inc. markets its products under the Diamox, Fioricet, Fiorinal, Fiorinal w/ Codeine #3, Cleocin, Danocrine, Bentyl, Tenuate, Dospan, Lanoxin, Adoxa, Periostat, Prolixin, Dilaudid, Levoxyl, Synthroid, Loxitane, Adipex-P, Fastin, Salagen, Mysoline, Benemid, Rifadin, Brethine, Dyazide, and Actigall brands. It also manufactures active pharmaceutical ingredients. The company sells its pharmaceutical products to generic pharmaceutical distributors, drug wholesalers, chain drug retailers, private label distributors, mail-order pharmacies, other pharmaceutical manufacturers, managed care organizations, hospital buying groups, governmental entities, and health maintenance organizations. It has development and supply agreements with Azad Pharma AG, Swiss Caps of Switzerland, Pharma 2B, and the GC Group of Israel, as well as with Jerome Stevens Pharmaceuticals, Inc., Cerovene, and Summit Bioscience LLC. The company was founded in 1942 and is based in Philadelphia, Pennsylvania.

356 Employees
Last Reported Date: 09/12/13
Founded in 1942

lannett co inc (LCI) Top Compensated Officers

Chief Executive Officer, President, Director ...
Total Annual Compensation: $437.5K
Chief Financial Officer, Vice President of Fi...
Total Annual Compensation: $270.2K
Chief Operating Officer
Total Annual Compensation: $255.9K
Chief Compliance Officer and Vice President o...
Total Annual Compensation: $174.0K
Chief Information Officer and Vice President ...
Total Annual Compensation: $170.0K
Compensation as of Fiscal Year 2013.

lannett co inc (LCI) Key Developments

Lannett Company, Inc. Receives FDA Approval for Codeine Sulfate Tablets USP, 15 Mg, 30 Mg and 60 Mg

Lannett Company, Inc. announced that it has received approval from the U.S. Food and Drug Administration (FDA) of its Abbreviated New Drug Application (ANDA) for Codeine Sulfate Tablets USP, a schedule II controlled substance, 15 mg, 30 mg and 60 mg, the therapeutic equivalent to the reference listed drug, Codeine Sulfate Tablets USP 15 mg, 30 mg and 60 mg, of Roxane Laboratories, Inc.

Lannett Company, Inc. Presents at ROTH Healthcare Corporate Access Day - London, Jun-24-2014

Lannett Company, Inc. Presents at ROTH Healthcare Corporate Access Day - London, Jun-24-2014 . Venue: The Dorchester, 3 Tilney Street, London, W1K 1BJ, United Kingdom.

Lannett Company, Inc.(NYSE:LCI) added to S&P 1000 Index

Lannett Company, Inc.(NYSE:LCI) added to S&P 1000 Index


Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
LCI:US $46.91 USD +0.64

LCI Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Akorn Inc $34.63 USD +0.51
Covisint Corp $4.54 USD -0.09
GlaxoSmithKline SAE £12.80 EGP 0.00
Momenta Pharmaceuticals Inc $11.73 USD +0.30
SciClone Pharmaceuticals Inc $5.10 USD +0.06
View Industry Companies

Industry Analysis


Industry Average

Valuation LCI Industry Range
Price/Earnings 42.2x
Price/Sales 7.0x
Price/Book 6.2x
Price/Cash Flow 44.9x
TEV/Sales 6.6x

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact LANNETT CO INC, please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at